# CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

> **NCT06445803** · PHASE1 · RECRUITING · sponsor: **Rong Tao** · enrollment: 48 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
- B-cell Lymphoma Refractory
- B-cell Lymphoma Recurrent

## Interventions

- **BIOLOGICAL:** KQ-2002 CAR-T cells （CD19/CD22 CAR T-Cells）

## Key facts

- **NCT ID:** NCT06445803
- **Lead sponsor:** Rong Tao
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-31
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06445803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06445803, "CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06445803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*